Results 1 to 10 of about 590,054 (253)
Medical Clinics of North America, 1979 Human liver transplantation, which was first performed in man in Denver 15 years ago, has finally come of age in the past 2 years. The 1 year survival has improved from 28 per cent to 50 per cent in the recent Denver Second Series.
Koep, LJ, Starzl, TE, Terblanche, J
core +6 more sources
Acute pancreatitis after liver transplantation: incidence and contributing factors [PDF]
, 1995 In order to assess the incidence and possible predisposing and contributing factors in the development of acute pancreatitis after liver transplantation, we reviewed the medical records of all 1832 adult patients who underwent 2161 orthotopic liver ...
N. V. Krokos +7 more
openalex +4 more sources
Gastroenterology, 1997 The development of liver transplantation has been difficult. However, substantial advances have been made mostly because of better surgical techniques and because of better postoperative management. It has been necessary for surgeons to be more inquisitive about the reasons for post-transplantation liver dysfunction rather than to ascribe hepatic ...
G W, McCaughan, D J, Koorey
+10 more sources
Jornal de Pediatria, 2000 OBJECTIVE: To review the clinical aspects and the theoretical basis of liver transplantation in children, focusing mainly pre and post surgical periods. METHODS: References were obtained from computerized search in the National Library of Medicine (Medline), recent review articles, and personal files. RESULTS: Great development has occurred in surgical
C T, Ferreira +2 more
openaire +4 more sources
Current Opinion in Gastroenterology, 1989 The 1-year survival rates of around 70% that are now being achieved have resulted in the acceptance of liver transplantation as a treatment for end-stage liver disease. The number of patients undergoing transplantation is increasing rapidly and the indications are widening.
J M, Neuberger, D H, Adams
+6 more sources
BMC Cancer, 2020 Background The prognosis of patients with combined hepatocellular carcinoma and intrahepatic cholangiocarcinoma (CHC) is usually poor, and effective adjuvant therapy is missing making it important to investigate whether these patients may benefit from ...
Wei-Ren Liu +14 more
doaj +1 more source
Cancer Cell International, 2022 Background While the correlation between PD-L1 expression and KRAS mutation has been previously reported in other solid tumors such as non-small cell lung cancer (NSCLC), whether PD-L1 can be modulated by ERK signaling downstream of KRAS in intrahepatic ...
Zheng Gao +15 more
doaj +1 more source
Canadian Journal of Gastroenterology and Hepatology, 2022 Objective. Intrahepatic cholangiocarcinoma (iCCA) is a primary liver malignancy with a poor prognosis and limited treatment. Cisplatin with gemcitabine is used as the standard first-line chemotherapy regimen; however, there is still no robust evidence ...
Peixin Huang +6 more
doaj +1 more source
BMC Surgery, 2022 Background Previous studies have reported the surgical resection (SR) and radiofrequency ablation (RFA) could achieve comparable recurrence-to-death survival (RTDS).
Youwei Wu +5 more
doaj +1 more source